David Robson has spent his entire 30+ year career within the development-to-supply process of the medical device industry. During that time, he has held roles and management positions within several startups, several $100M+ OEMs, and 17 years at a medical device development firm. His exposure to a wide array of clinical fields and technical solutions within all regulatory classifications has resulted in a broad-minded perspective on how (depending on the circumstances) an outsourcing model may or may not be effectively applied. Currently, Robson is COO of a medical device startup—Iantrek Inc.—which is concentrating on instruments used in microinterventional glacoma surgery (MIGS).